Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/1991
03/09/1991WO1991003489A1 Structural alterations of the egf receptor gene in human gliomas
03/09/1991WO1991003483A1 Tsh receptor
03/09/1991CA2024918A1 Fused proteins and production thereof
03/08/1991WO1991003555A1 Interleukin-4 receptors
03/08/1991CA2066240A1 Interleukin-4 receptors
03/08/1991CA2024697A1 Protein having anticoagulant properties
03/07/1991WO1991002807A1 Production of biologically active insulin-like growth factor i from high expression host cell systems
03/07/1991WO1991002796A1 Cystic fibrosis gene
03/07/1991WO1991002756A1 Prohormone cleavage site blocking antibody
03/07/1991WO1991002754A1 Fusion proteins comprising gm-csf and il-3
03/07/1991WO1991002753A1 Anticoagulant protein
03/07/1991WO1991002751A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs
03/07/1991WO1991002748A1 Rubella e1 peptides
03/07/1991WO1991002540A1 Compositions for the inhibition of protein hormone formation and uses thereof
03/07/1991WO1991000920A3 Process for preparing a protein by a fungus transformed by multicopy integration of an expression vector
03/07/1991DE3928861A1 Monoclonal antibodies specific for interleukin 8 - reagents for quantitative sandwich ELISA and affinity purificn.
03/07/1991CA2005398A1 Alginase and a process for production thereof and bacteria used, as well as a method for decomposition of alginic acid
03/06/1991EP0415801A1 Monoclonal antibodies against activated microglial cells
03/06/1991EP0415565A2 Enhanced expression of heterologous proteins in recombinant hosts in a non-growth media
03/06/1991EP0415557A2 Separation of anti-metal chelate antibodies
03/06/1991EP0415470A2 Aminopeptidase
03/06/1991EP0415321A1 Oligodendrocyte cytotoxic factor
03/06/1991EP0415219A1 ANF-Antagonist
03/06/1991EP0414921A1 Human monoclonal antibody reactive with pseudomonas aeruginosa, cell which produces the antibody, method of production, and pharmaceutical preparation
03/06/1991EP0414812A1 Extraction of human interleukin-4 from bacteria
03/06/1991EP0414807A1 Human mammary cell growth inhibitor and methods of production and use
03/06/1991EP0414728A1 NOVEL NEUTROPHIL CHEMOTACTIC FACTOR, CLONED cDNA AND MONOCLONAL ANTIBODIES THERETO
03/06/1991EP0162054B1 Production of cdna representing hepatitis a viral sequences
03/05/1991WO1991003570A1 Monoclonal antibody against infectious pancreatic nephrosis virus having neutralizing activity
03/05/1991US4997915 Purification of pertussis toxins
03/05/1991CA2039168A1 Neutralizing monoclonal antibody to infectious pancreatic necrosis virus
03/05/1991CA2024145A1 Expression plasmids and use thereof
03/02/1991CA2024053A1 Anf-antagonist
03/01/1991WO1991003738A1 Immunochemical reagents and methods for monitoring industrial fermentation
03/01/1991WO1991003484A1 Abo genotyping
03/01/1991CA2065352A1 Abo genotyping
03/01/1991CA2039178A1 Reactives and immunochemical methods for measuring microorganisms growing and proteins quantity during industrial fermentation
03/01/1991CA2024030A1 Oligodendrocyte cytotoxic factor
02/1991
02/27/1991EP0414374A2 Novel antigens and methods for their preparation
02/27/1991EP0414355A1 Feline interferon and process for production thereof by a silkworm virus vector
02/27/1991EP0414297A1 Efficient production of mutant proteases
02/27/1991EP0414178A2 Non-human primate CD4 polypeptides and human CD4 molecules capable of being glycosylated
02/27/1991EP0414134A1 Method for producing antiviral protein utilizing E.coli transformant, and gene and E.coli vector used in the method
02/27/1991EP0414035A2 Gibbon ape leukemia virus receptor
02/27/1991EP0413967A1 Novel antibiotic
02/27/1991EP0413908A2 Soluble extracellular fragment of the human IFN-beta 2/IL-6 receptor, its preparation and pharmaceutical compositions containing it
02/27/1991EP0413818A1 Process for producing a human neutrophil chemotactic factor polypeptide.
02/27/1991EP0413794A1 Periodontal and bone regeneration factor, materials and methods
02/27/1991EP0413762A1 Peptide analogs and their use as haptens to elicit catalytic antibodies
02/27/1991EP0413738A1 Vectors encoding hcmv glycoprotein and expression products
02/27/1991EP0413721A1 Human gm-csf variants
02/27/1991CN1049524A Process for production of hydrolyzed vegestable proteins and product therefrom
02/27/1991CN1049523A Escherichia coli vaccine
02/27/1991CN1049522A Fermentation extraction of fugu peptide and its determination
02/26/1991US4996297 contraceptives for non-rodent mammals
02/26/1991US4996148 Aerobic fermentation of Kibdelosporangium
02/26/1991CA2023969A1 Production of biologically active insulin-like growth factor i from high expression host cell systems
02/26/1991CA1280693C Purification of pertussis antigens
02/25/1991CA2023819A1 Gibbon ape leukemia virus receptor
02/24/1991WO1991002977A1 Wound healing preparations containing heparanase
02/24/1991WO1991002743A1 Non-human primate cd4 polypeptides, fusions thereof, dna encoding, and uses thereof
02/24/1991CA2065744A1 Wound healing preparations containing heparanase
02/24/1991CA2065010A1 Non-human primate cd4 polypeptides, fusions thereof, dna encoding, and uses thereof
02/22/1991WO1991002744A1 Bone-specific protein
02/22/1991CA2064878A1 Bone-specific protein
02/21/1991WO1991002252A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
02/21/1991WO1991002079A1 Monoclonal antibodies against a tumor-associated antigen
02/21/1991WO1991002078A1 Tumour necrosis factor binding ligands
02/21/1991WO1991002074A1 Method for obtaining polypeptides in a cell-free translation system
02/21/1991WO1991002066A1 Production of heterologous proteins in plants and plant cells
02/21/1991WO1991002063A1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof
02/21/1991WO1991002062A2 C-erbb-2 external domain: gp75
02/21/1991WO1991002061A1 Recombinant human thyroid peroxidase
02/21/1991WO1991002058A1 Production of vascular endothelial cell growth factor
02/21/1991WO1991001744A2 Uses of interleukin-4 and method for purifying it
02/21/1991WO1991001743A1 Stabilized protein or peptide conjugates
02/21/1991WO1991001639A1 Methods and compositions for ameliorating the symptoms of sepsis
02/21/1991CA2064753A1 Uses of interleukin-4 and method for purifying it
02/21/1991CA2060663A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
02/20/1991EP0413622A1 Albumin derivatives with therapeutic functions
02/20/1991EP0413477A1 Monoclonal Antibody
02/20/1991EP0413383A1 Mutants of human interleukin-3
02/20/1991EP0413378A1 Escherichia coli vaccine
02/20/1991EP0413024A1 Protein having activity of inhibiting inflammation-inducing phospholipase a2
02/20/1991EP0412970A1 Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein
02/19/1991WO1991002755A1 Fibulin
02/19/1991WO1991002546A1 A reagent for the detection of fibrinolytic activity
02/19/1991US4994565 Nucleotide sequence of gene specifically expressed by insulinoma
02/19/1991US4994556 Antitumor agents
02/19/1991US4994555 Process for recovery of glycopeptidic antibiotics
02/19/1991US4994554 Probursin
02/19/1991US4994380 Transducing replicable plasmid into cell
02/19/1991US4994369 T-cell activation related gene
02/19/1991US4994271 BMY-40800 antitumor antibiotics
02/19/1991CA2065147A1 Reagent for the detection of fibrinolytic activity
02/19/1991CA2064818A1 Fibulin
02/19/1991CA1280379C Peptides and compositions
02/19/1991CA1280363C Peptide composition and method for the detection of antibodies to htlv-iii
02/17/1991CA2020700A1 Compositions for the inhibition of protein hormone formation and uses thereof
02/16/1991CA2023250A1 Cleavage site blocking antibody to prohormone proteins and uses thereof